“We have demonstrated, for the first time worldwide, that CRISPR-Cas9 can be used to incorporate a desired sequence into ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

Jyoti Structures Ltd. key Products/Revenue Segments include Transmission Lines, Towers & Structures and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the ...